StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJul 31, 2026, 04:32 PM

Recursion Grants 3.23M Inducement RSUs to 24 New Employees

AI Summary

Recursion Pharmaceuticals announced the grant of inducement restricted stock unit (RSU) awards covering 3,234,866 shares of its Class A common stock to 24 new employees. These awards were approved by the Compensation Committee on July 27, 2026, under the company's 2024 Inducement Equity Incentive Plan. The grants serve as a material inducement for the employees' commencement of employment, with vesting tied to continued employment.

Key Highlights

  • Granted 3,234,866 inducement restricted stock units (RSUs).
  • Awards were distributed among 24 new employees.
  • Approved by the Compensation Committee on July 27, 2026.
  • Granted under Recursion's 2024 Inducement Equity Incentive Plan.
  • Vesting begins after one year (1/4th), then 1/16th quarterly thereafter.
  • Awards are contingent on the recipient's continued employment.